3-methyl-4',6-dihydroxy-3',5'-dibromoflavone has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlow, JW; Curtis, AJ; Loidl, NM; Raggatt, LE; Stockigt, JR; Topliss, DJ | 1 |
1 other study(ies) available for 3-methyl-4',6-dihydroxy-3',5'-dibromoflavone and Hepatocellular Carcinoma
Article | Year |
---|---|
Drug competition for intracellular triiodothyronine-binding sites.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; Carcinoma, Hepatocellular; Fatty Acids, Nonesterified; Flavonoids; Furosemide; Humans; Iodide Peroxidase; Liver; Liver Neoplasms; Macaca fascicularis; Sex Hormone-Binding Globulin; Sulfobromophthalein; Triiodothyronine; Tumor Cells, Cultured | 1994 |